ClinicalTrials.gg
Drug

Belantamab mafodotin clinical trials

Also written GSK2857916 and Blenrep.

studies test it
56
open now
19
in phase 3
9
first study started
2014

How each study uses belantamab mafodotin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the belantamab mafodotin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
5 Aug 2020 · Blenrep · BLA 761158 (FDA, Purple Book)
European Union
25 Aug 2020 · Blenrep · EMEA/H/C/004935 (EMA; now expired)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Belantamab mafodotin
48
Belantamab Mafodotin-blmf
4
J6M0-mcMMAF
4
Belamaf
2

Brand

Blenrep
11

Development codes

GSK2857916
18

Studies by the year they started

56 studies that test it; most in 2021 (14)

Studies that test belantamab mafodotin, by start year
YearStudies
20141
20181
20195
20206
202114
202211
20234
20245
20251
20268

By phase

A phase 1/2 study counts in both.

Phase 1
30
Phase 2
35
Phase 3
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 25 · Other 31

GlaxoSmithKline (25) · M.D. Anderson Cancer Center (3) · Canadian Myeloma Research Group (2) · PETHEMA Foundation (2) · Hellenic Society of Hematology (2) · Mayo Clinic (2) · Roswell Park Cancer Institute (1) · University of Pennsylvania (1)

Often tested with

Tested in the same studies.

Dexamethasone (12) · Pomalidomide (7) · Lenalidomide (5) · Nirogacestat (4) · Bortezomib (3) · Isatuximab (2) · Venetoclax (2) · Daratumumab (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 7

Studies that test belantamab mafodotin.

Studies

Open first, then newest update. How each study uses belantamab mafodotin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 56

See all 56 studies that test belantamab mafodotin →

Given beside what is tested · 11 — belantamab mafodotin is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with belantamab mafodotin

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call belantamab mafodotin · ClinicalTrials.gg INT001113

  • MeSH (NLM) C000631691belantamab mafodotinConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) DB1041CXDGBELANTAMAB MAFODOTINConfirmed FDA, NLM, Wikidata
  • Wikidata Q98139657belantamab mafodotinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C114299Belantamab MafodotinOne source FDA
  • DrugBank DB15719One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.